Suppliers / Zibo Xinhua - Perrigo Pharmaceutical

Zibo Xinhua - Perrigo Pharmaceutical

China 1 employees Updated 9 July 2026

Zibo Xinhua - Perrigo Pharmaceutical is an API manufacturer based in China. It holds one active US drug master file. Its GMP standing is certified by MHRA (UK), US FDA and EMA. Its most recent recorded inspection, by US FDA, closed on 6 September 2024 as VAI.

1
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
3 of 3 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 6 September 2024 VAI US FDA
  • 13 March 2015 NAI US FDA
  • 20 February 2009 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
ZIBO, China Not on file
China, China 3005447913

What they file, and where

Molecule Regulators Docs
Ibuprofen US FDA 1

Also appears on these molecule pages

Ibuprofen API

Filings and GMP by regulator

Regulator Filings GMP certificates
MHRA (UK) None 1
US FDA None 1
EMA None 1

Questions about Zibo Xinhua - Perrigo Pharmaceutical

Does Zibo Xinhua - Perrigo Pharmaceutical hold a US DMF or a CEP?
Zibo Xinhua - Perrigo Pharmaceutical holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Zibo Xinhua - Perrigo Pharmaceutical FDA-registered?
One site operated by Zibo Xinhua - Perrigo Pharmaceutical carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Zibo Xinhua - Perrigo Pharmaceutical's last inspection go?
The most recent inspection on record closed on 6 September 2024 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 3 inspections are on file.
Where does Zibo Xinhua - Perrigo Pharmaceutical manufacture?
2 registered sites are on record, in China (Zibo and China). Every site is listed on this page with the register it came from.
What does Zibo Xinhua - Perrigo Pharmaceutical make?
1 molecule is on record against Zibo Xinhua - Perrigo Pharmaceutical, including Ibuprofen. Each links through to that molecule's full manufacturer list.
Which regulators recognise Zibo Xinhua - Perrigo Pharmaceutical's GMP?
Current GMP certificates are on record from MHRA (UK), US FDA and EMA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Zibo Xinhua - Perrigo Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 6 September 2024.

Comparable suppliers

Solara Active Pharma Sciences shares 1 molecule Piramal Pharma shares 1 molecule SMS Pharmaceuticals shares 1 molecule Dipharma Francis shares 1 molecule Shandong Xinhua Pharmaceutical shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates